Provided by Tiger Trade Technology Pte. Ltd.

Perspective Therapeutics

3.16
+0.05001.61%
Post-market: 3.160.00000.00%19:41 EDT
Volume:910.73K
Turnover:2.86M
Market Cap:360.24M
PE:-2.38
High:3.18
Open:3.11
Low:3.08
Close:3.11
52wk High:6.16
52wk Low:1.96
Shares:114.00M
Float Shares:67.88M
Volume Ratio:1.15
T/O Rate:1.34%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3300
EPS(LYR):-1.3971
ROE:-39.57%
ROA:-22.28%
PB:1.11
PE(LYR):-2.26

Loading ...

BMO Capital Initiates Perspective Therapeutics at Outperform

MT Newswires Live
·
Aug 19

Perspective Therapeutics is Maintained at Neutral by B of a Securities

Dow Jones
·
Aug 15

BofA Securities Adjusts Perspective Therapeutics Price Target to $5 From $6

MT Newswires Live
·
Aug 14

RBC Capital Sticks to Their Buy Rating for Perspective Therapeutics (CATX)

TIPRANKS
·
Aug 12

Perspective Therapeutics's NET Program Data May Allow Phase 3 Trial Start, Value Inflection, RBC Says

MT Newswires Live
·
Aug 11

Wedbush Sticks to Their Buy Rating for Perspective Therapeutics (CATX)

TIPRANKS
·
Aug 11

Perspective Therapeutics (CATX) Receives a Buy from Truist Financial

TIPRANKS
·
Aug 11

Perspective Therapeutics price target lowered to $14 from $16 at Piper Sandler

TIPRANKS
·
Aug 11

Perspective Therapeutics Q2 EPS $(0.22) Beats $(0.26) Estimate, Sales $81.000K Miss $83.154K Estimate

Benzinga Earnings
·
Aug 11

Perspective Therapeutics Q2 EPS USD -0.22

Reuters
·
Aug 11

Perspective Therapeutics Q2 Net Loss Widens on Higher R&D Costs

Reuters
·
Aug 11

Perspective Therapeutics Q2 Net Income from Cont Ops USD -26.983 Million

THOMSON REUTERS
·
Aug 11

Perspective Therapeutics Provides Recent Business Highlights and Reports 2Q 2026 Results

THOMSON REUTERS
·
Aug 11

Perspective Therapeutics Advances 212Pb Radiopharmaceutical Oncology Platform

TIPRANKS
·
Aug 04

Perspective Therapeutics to Provide Business Highlights and Report Second Quarter 2026 Financial Results

GlobeNewswire
·
Jul 31

Perspective Therapeutics' Neuroendocrine Tumor Therapy Receives EU Orphan Drug Designation

MT Newswires Live
·
Jul 28

Perspective Therapeutics Wins EU Orphan Drug Status for [212Pb]VMT-α-NET in GEP-NETs

Reuters
·
Jul 28

Perspective Therapeutics Receives European Orphan Medicinal Product Designation for [212PB]Vmt-Α-Net in Gep-Nets

THOMSON REUTERS
·
Jul 28

Perspective Therapeutics Announces Acceptance of Vmt-α-net Data for Oral Presentation at the Esmo Congress 2026

THOMSON REUTERS
·
Jul 18

Perspective Therapeutics Announces Acceptance of VMT-α-NET Data for Oral Presentation at the ESMO Congress 2026

GlobeNewswire
·
Jul 18